*|MC:SUBJECT|*
bioRN News September 2026
Dear *|FNAME|* *|LNAME|*,

September has given us plenty of reasons to look at the Rhine-Main-Neckar life science ecosystem with confidence.

Six ERC Grants went to researchers in the region. Two new European collaborative projects led from Heidelberg secured almost €8 million in funding. Heidelberg University achieved top international rankings in Medical and Life Sciences. And another major development is strengthening the region’s position in AI-driven medicine. On 1 October, the new Institute for Medical AI (IMAI) launches in Heidelberg under the leadership of Prof. Jakob Nikolas Kather, bringing research and clinical application of AI even closer together. We are particularly excited that Prof. Kather will join us as a keynote speaker at life - the biomedical convention 2027, 3 Feb at the Heidelberg Congress Center where AI in Health will be one of our two main tracks. (visit our website to receive more information about life)

Scientific excellence like this is one of the great strengths of our region. But its impact grows when the right connections are made around it, and September was full of them. That´s why we brought industry and academia together for a stimulating exchange on the latest approaches in platforms for target ID and new approach methodologies, at the exclusive Industry Academia Day. (more info here). The following day we connected selected startups with investors at the Life Science Investors´Day Heidelberg and created opportunities for conversations that can develop far beyond a single event. (find more information here ).

Our connections also reached beyond the region. At the K-Biotech Innovation Day, we welcomed five South Korean biotech and medtech start-ups to Heidelberg – opening doors to potential research and clinical collaborations, licensing, distribution and strategic partnerships between two highly innovative ecosystems.

And within the region, our growing Rhine-Neckar Lab Automation Community met at BioLabs Heidelberg to exchange practical experience around automation, digitalisation and the future of laboratory workflows. (more info here)

Different topics, different formats,  but one common thread: making the scientific and entrepreneurial strengths of our region visible and creating the connections that help them move forward.

And there is much more to discover. Our new issue of life - the bioRN Life Science Cluster magazine captures another snapshot of the companies, research institutions, technologies and collaborations shaping the Rhine-Main-Neckar life science ecosystem. (find the magazine and more news on our website)

Make the most of the September sunshine today and plan your next visit to our ecosystem. Perhaps at one of our upcoming events?

Upcoming events in October: 

  • bioRN M2M Member to Member featuring NMI Natural and Medical Sciences Institute at the University of Tübingen in Reutlingen, October 7th 12pm: Registration
    here
  • bioRN C-Level-Circle: The Talent Advantage - hosted by PROGEN, October 8th, 6pm, More information here 
  • bioRN MarCom SUMMIT on the topic: Targeted Communication.  22 October, 9-1pm, Agenda and Registration here . 
  • bioRN Lounge featuring Prof. Dr. Matthias Rädle, Technische Hochschule Mannheim on the topic: Aspects of spectroscopic bio/chemical process control, 27 October, 6pm @Urban Kitchen. Registration opens soon!

Don´t miss further news and events which you will find at the bioRN website.
We look forward to seeing you soon!

Kind regards,

Stephanie Füller 
PR Manager
bioRN Life Science Cluster 
LinkedIn
Twitter
Website
01 | Research Highlights & News
02 | New Members
03 | Opportunities
04 | Event Spotlights
05 | Event Calendar & Discounts
06 | Open Positions
01 | Research Highlights & News

BioMed X Relocates Global Headquarters to Heidelberg Innovation Park (hip) and Enters Partnership with BioLabs [more]

DKFZ:
  • Heisenberg Professorship for Aurélie Ernst [more]
  • Triple ERC Success at the German Cancer Research Center [more]
New Publication by Gen-H: Multi-plasmid antibiotic-free fermentation [more]

GenScript Joins Lilly TuneLab to Advance AI-Enabled Drug Discovery [more]

Heidelberg Pharma:
  • Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates [more]
  • Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China [more]
Karlsruhe Institute of Technology (KIT): Enzymes in small beads for a more sustainable chemistry  [more]

Max Planck Institute for Medical Research:
  • Every electron counts: most detailed protein structure to date revealed [more]
  • ERC Starting Grant for Stephanie Möllmert [more]
NMI - Natural and Medical Sciences Institute at the University of Tübingen:
  • Funding Paves the Way for the Startup immuneAdvice to Move into Clinical Studies [more]
  • A local barrier against respiratory viruses – NMI participates in new project with Fraunhofer IGB [more]
  • Making Medications Safer: NMI Participates in the HEARTCORE Project [more]
From Cardiovascular Research to a Biotech Company: REVIER Therapeutics Launches with €6 Million [more]

Sanofi and Cheplapharm to create new strategic partnership in mature medicines [more]

Multi-Tissue Proteomics for Preclinical Safety: FluoSphera & Sciomics Launch Joint Service [more]

UKHD:
  • Heidelberg University Hospital is a founding member of MEDI:CUS [more]
  • Heidelberg Medical Students Remain at the Very Top in Germany [more]
  • Professor Jakob Nikolas Kather Appointed Hopp Foundation Professor of “Artificial Intelligence in Medicine” and Founding Director of the New Institute for Medical AI (IMAI) in Heidelberg [more]
  • The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg [more]
  • Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase [more]
  • Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body [more]

Universität Heidelberg:
  • Universität Heidelberg with Top Placings in latest Shanghai Subject Ranking  [more]
  • Possible new way to protect the heart during certain chemotherapy treatments [more]
  • Two ERC Starting Grants for Scientists at Universität Heidelberg [more]
YUMAB and ISAR Bioscience create platform for blood-brain-barrier drug delivery [more]
 

02 | New Members
Abbmira Therapeutics is a Swiss biotechnology company sculpting the innate immune system to fight cancer. Many tumors evade treatment by manipulating immune cells called macrophages, contributing to treatment resistance and poor patient outcomes. Abbmira develops first-in-class small-molecule medicines designed to precisely reprogram these cells and restore their natural anti-tumor activity.
In pharma, biotech and medtech, enterprise value growth falters when organisations cannot meet scaling, regulatory and operational demands. GrueneNeun builds start-ups and scale-ups around their science; in established firms, we stop friction, rework and regulatory failure eroding value. They diagnose, design and implement change until organisational anatomy, physiology and psychology interact to create Emergent Value-Creation Coordination: the organisation connects information, decisions, authority, expertise, resources and action sufficiently to recognise shifting demands and adapt execution before they outgrow organisational capacity and erode value.

03 | Opportunities


In this section we provide selected information on funding calls and events. On our website in the section startup support you will find a calendar with more Open Calls, Pitches, Knowledge Transfer and Closings.

Open Calls:  

  • Innovative Health Initiative (IHI) call 13 :IHI call 13 is a two-stage call with topics on accelerating healthcare innovation through networks, reducing animal use in drug safety studies, and decoding the immuno-science of diseases affected by ageing and the immune system. Deadline: 8. October  [more]
  • EIC Pathfinder Challenges Ausschreibung zu Biotechnologie für gesundes Altern. Deadline  28. October  [more]
  • SME Access Pilot: Funding for Imaging Services for Start-ups and SMEs, Deadline 13. November  [more]
Knowledge Transfer:  
  • From lab to market: aligning IP with investment and growth, Seminar 17 November [more]

04 | Event Spotlights

SAVE THE DATE /NEW EVENTS

05 | Event Calendar & Discounts
„Welcome Sessions – German Social Security Made Easy” | Webinar, Techniker Krankenkasse
Every 1st Thursday of the Month - Online >>

 
Wittenstein Biointelligence Award
October 06, 2026 - Stuttgart, Germany >>
 
bioRN M2M Member to Member featuring NMI Natural and Medical Sciences Institute at the University of Tübingen in Reutlingen
October 07, 2026 - Online >>
bioRN C-Level Circle: The Talent Advantage – hosted by PROGEN
October 08, 2026 - 6-9pm Café KLINKER Heidelberg >>
i2i Academy – From Idea to IND
October 12, 2026 - Basel, Switzerland >>
 
EMBL Imaging Centre Symposium
October 13-14, 2026 - Heidelberg, Germany >>
 
Accelerate Discovery Tour Featuring smart solutions for NGS workflows, cell-based assays, and lab automation
October 14, 2026 - Mannheim, Germany >>
 
Festival of Biologics 2026
October 13-15, 2026 - Basel, Switzerland >>
Free Tickets for pharmaceutical, biotech, academia and regulators!
20 % Discount for Members!
 
bioRN MarCom SUMMIT 
>>Targeted communication<<
October 22, 2026, 9-1pm - Heidelberg, Germany >>


 
bioRN Lounge with Prof. Dr. Matthias Rädle, Technische Hochschule Mannheim 
>> Aspects of spectroscopic  bio/chemical process control <<
October 27, 2026, 6pm - Urban Kitchen, Heidelberg, Germany >>



 
Industry Impact Conference
October 29, 2026 - Stuttgart, Germany >>
 
Falling Walls 
November 06-9, 2026 - Berlin, Germany >>
Discount Tickets for bioRN members
for more information contact Alexya Azhakesan  (aa@biorn.org)

 
Bio-Europe 2026
November 09-11, 2026 - Köln, Germany >>
12% Discount for Members!
Logo display at the The Länd booth: BioRN Members that visit Bio-Europe may display their logo at The Länd booth. For more information please contact Nicole Hecht (nh(at)biorn.org).

 
Targeted Drug Delivery | 5th Joint Meeting of GBM & BioPharma Cluster South German
November 27, 2026 - Ulm, Germany >>

 
BioFIT and MedFIT 2026
December 10-11, 2026 - Marseille, France >>
20 % Discount for Members!
 
Save-the-Date: Aktuelle Trends im Biomanufacturing - Erfolgsmodell Kooperation
February 24-25, 2027 - Ulm, Germany
More Infos will follow :)
Curious 2027 comes to HEIDELBERG
July 07-08, 2027 - Heidelberg, Germany  >>
20 % Discount for Members!

06 | Open Positions

Fundess GmbH: 
  • Scientific Consultant Fördermittel & Innovationsfinanzierung (m/w/d) [more]
WMT AG: 
  • Internship Positions in Molecular Biology [more]
Tweet Tweet
Forward Forward
Share Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Stephanie Füller

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*